BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34050869)

  • 1. IP
    Parys JB; Bultynck G; Vervliet T
    Prog Mol Subcell Biol; 2021; 59():215-237. PubMed ID: 34050869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival.
    Ivanova H; Vervliet T; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2164-83. PubMed ID: 24642269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.
    Schulman JJ; Wright FA; Kaufmann T; Wojcikiewicz RJH
    J Biol Chem; 2013 Aug; 288(35):25340-25349. PubMed ID: 23884412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 3 IP
    Rosa N; Sneyers F; Parys JB; Bultynck G
    Int Rev Cell Mol Biol; 2020; 351():101-148. PubMed ID: 32247578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological consequences of isoform-specific IP
    Kerkhofs M; Seitaj B; Ivanova H; Monaco G; Bultynck G; Parys JB
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1707-1717. PubMed ID: 29906486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IP
    Kania E; Roest G; Vervliet T; Parys JB; Bultynck G
    Front Oncol; 2017; 7():140. PubMed ID: 28725634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 80K-H interacts with inositol 1,4,5-trisphosphate (IP3) receptors and regulates IP3-induced calcium release activity.
    Kawaai K; Hisatsune C; Kuroda Y; Mizutani A; Tashiro T; Mikoshiba K
    J Biol Chem; 2009 Jan; 284(1):372-380. PubMed ID: 18990696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
    Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
    J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP
    Roest G; La Rovere RM; Bultynck G; Parys JB
    Adv Exp Med Biol; 2017; 981():149-178. PubMed ID: 29594861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.
    Vervloessem T; Yule DI; Bultynck G; Parys JB
    Biochim Biophys Acta; 2015 Sep; 1853(9):1992-2005. PubMed ID: 25499268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of Ca
    Ando H; Kawaai K; Bonneau B; Mikoshiba K
    Adv Biol Regul; 2018 May; 68():64-76. PubMed ID: 29287955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights in the IP
    Parys JB; Vervliet T
    Adv Exp Med Biol; 2020; 1131():243-270. PubMed ID: 31646513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IP3 receptor/Ca2+ channel and its cellular function.
    Mikoshiba K
    Biochem Soc Symp; 2007; (74):9-22. PubMed ID: 17233576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform- and species-specific control of inositol 1,4,5-trisphosphate (IP3) receptors by reactive oxygen species.
    Bánsághi S; Golenár T; Madesh M; Csordás G; RamachandraRao S; Sharma K; Yule DI; Joseph SK; Hajnóczky G
    J Biol Chem; 2014 Mar; 289(12):8170-81. PubMed ID: 24469450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.
    Akl H; Bultynck G
    Biochim Biophys Acta; 2013 Apr; 1835(2):180-93. PubMed ID: 23232185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Ca2+ in triggering inositol 1,4,5-trisphosphate receptor ubiquitination.
    Alzayady KJ; Wojcikiewicz RJ
    Biochem J; 2005 Dec; 392(Pt 3):601-6. PubMed ID: 16134970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol (1,4,5)-Trisphosphate Receptors in Invasive Breast Cancer: A New Prognostic Tool?
    Foulon A; Rybarczyk P; Jonckheere N; Brabencova E; Sevestre H; Ouadid-Ahidouch H; Rodat-Despoix L
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP
    Bartok A; Weaver D; Golenár T; Nichtova Z; Katona M; Bánsághi S; Alzayady KJ; Thomas VK; Ando H; Mikoshiba K; Joseph SK; Yule DI; Csordás G; Hajnóczky G
    Nat Commun; 2019 Aug; 10(1):3726. PubMed ID: 31427578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological Regulatory Network (BRN) Analysis and Molecular Docking Simulations to Probe the Modulation of IP
    Ismatullah H; Jabeen I; Saeed MT
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.